Literature DB >> 18574672

Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.

Birgitte B Olsen1, Tine Rasmussen, Karsten Niefind, Olaf-Georg Issinger.   

Abstract

Altogether 2 holoenzymes and 4 catalytic CK2 constructs were expressed and characterized i.e. CK2alpha(2)1-335 beta2; CK2alpha'-derived holoenzyme; CK2alpha1-335; MBP-CK2alpha'; His-tagged CK2alpha and His-tagged CK2alpha'. The two His-tagged catalytic subunits were expressed in insect cells, all others in Escherichia coli. IC50 studies involving the established CK2 inhibitors DMAT, TBBt, TBBz, apigenin and emodin were carried out and the Ki values calculated. Although the differences in the Ki values found were modest, there was a general tendency showing that the CK2 holoenzymes were more sensitive towards the inhibitors than the free catalytic subunits. Thermal inactivation experiments involving the individual catalytic subunits showed an almost complete loss of activity after only 2 min at 45 degrees C. In the case of the two holoenzymes, the CK2alpha'-derived holoenzyme lost ca. 90% of its activity after 14 min, whereas CK2alpha2(1-335) beta2 only showed a loss of ca. 40% by this time of incubation. Gel filtration analyses were performed at high (500 mM) and low (150 mM) monovalent salt concentrations in the absence or presence of ATP. At 500 mM NaCl the CK2alpha'-derived holoenzyme eluted at a position corresponding to a molecular mass of 105 kDa which is significantly below the elution of the CK2alpha(2)1-335 beta2 holoenzyme (145 kDa). Calmodulin was not phosphorylated by either CK2alpha2(1-335) beta2 or the CK2alpha'-derived holoenzyme. However, in the presence of polylysine only the CK2alpha(2)1-335 beta2 holoenzyme could use calmodulin as a substrate such as the catalytic subunits, in contrast to the CK2alpha'-derived holoenzyme which only phosphorylated calmodulin weakly. This attenuation may be owing to a different structural interaction between the catalytic CK2alpha' subunit and non-catalytic CK2beta subunit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574672     DOI: 10.1007/s11010-008-9824-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  50 in total

1.  GTP plus water mimic ATP in the active site of protein kinase CK2.

Authors:  K Niefind; M Pütter; B Guerra; O G Issinger; D Schomburg
Journal:  Nat Struct Biol       Date:  1999-12

Review 2.  Protein kinase CK2 and its role in cellular proliferation, development and pathology.

Authors:  B Guerra; O G Issinger
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

3.  Characterization of the alpha and beta subunits of casein kinase 2 by far-UV CD spectroscopy.

Authors:  O G Issinger; C Brockel; B Boldyreff; J T Pelton
Journal:  Biochemistry       Date:  1992-07-07       Impact factor: 3.162

Review 4.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

5.  Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A resolution.

Authors:  K Niefind; B Guerra; L A Pinna; O G Issinger; D Schomburg
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

6.  Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated beta-subunits.

Authors:  B Boldyreff; F Meggio; L A Pinna; O G Issinger
Journal:  Biochemistry       Date:  1993-11-30       Impact factor: 3.162

7.  Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.

Authors:  X Xu; P A Toselli; L D Russell; D C Seldin
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

8.  Ser2 is the autophosphorylation site in the beta subunit from bicistronically expressed human casein kinase-2 and from native rat liver casein kinase-2 beta.

Authors:  B Boldyreff; P James; W Staudenmann; O G Issinger
Journal:  Eur J Biochem       Date:  1993-12-01

9.  Pyrazole carboxamides and carboxylic acids as protein kinase inhibitors in aberrant eukaryotic signal transduction: induction of growth arrest in MCF-7 cancer cells.

Authors:  Tobias Persson; Christina W Yde; Jakob E Rasmussen; Tine L Rasmussen; Barbara Guerra; Olaf-Georg Issinger; John Nielsen
Journal:  Org Biomol Chem       Date:  2007-10-25       Impact factor: 3.876

10.  Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.

Authors:  Zhe Nie; Carin Perretta; Philip Erickson; Stephen Margosiak; Jia Lu; April Averill; Robert Almassy; Shaosong Chu
Journal:  Bioorg Med Chem Lett       Date:  2007-11-28       Impact factor: 2.823

View more
  11 in total

1.  Isolation of a CK2α subunit and the holoenzyme from the mussel Mytilus galloprovincialis and construction of the CK2α and CK2β cDNAs.

Authors:  Regina-Maria Kolaiti; Andrea Baier; Ryszard Szyszka; Sophia Kouyanou-Koutsoukou
Journal:  Mar Biotechnol (NY)       Date:  2010-10-05       Impact factor: 3.619

2.  Protein kinase CK2 and new binding partners during spermatogenesis.

Authors:  Nadja Mannowetz; Sabine Kartarius; Gunther Wennemuth; Mathias Montenarh
Journal:  Cell Mol Life Sci       Date:  2010-06-04       Impact factor: 9.261

3.  Predominance of CK2α over CK2α' in the mammalian brain.

Authors:  Ilaria Ceglia; Marc Flajolet; Heike Rebholz
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

4.  Evidence for aggregation of protein kinase CK2 in the cell: a novel strategy for studying CK2 holoenzyme interaction by BRET(2).

Authors:  Gerda M Hübner; Jane Nøhr Larsen; Barbara Guerra; Karsten Niefind; Milka Vrecl; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

5.  Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.

Authors:  Barbara Guerra; Jennifer Hochscherf; Nina Bjelkerup Jensen; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2015-05-12       Impact factor: 3.396

6.  Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage.

Authors:  Birgitte B Olsen; Shih-Ya Wang; Tina H Svenstrup; Benjamin P C Chen; Barbara Guerra
Journal:  BMC Mol Biol       Date:  2012-03-09       Impact factor: 2.946

7.  Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.

Authors:  Jennifer Hochscherf; Dirk Lindenblatt; Benedict Witulski; Robin Birus; Dagmar Aichele; Christelle Marminon; Zouhair Bouaziz; Marc Le Borgne; Joachim Jose; Karsten Niefind
Journal:  Pharmaceuticals (Basel)       Date:  2017-12-13

8.  Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.

Authors:  Andrea Baier; Jolanta Nazaruk; Anna Galicka; Ryszard Szyszka
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

Review 9.  The multifunctional role of phospho-calmodulin in pathophysiological processes.

Authors:  Antonio Villalobo
Journal:  Biochem J       Date:  2018-12-21       Impact factor: 3.857

10.  Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.

Authors:  Romualda Wąsik; Patrycja Wińska; Jarosław Poznański; David Shugar
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.